Insider · CIK 0001806548
KKR Phorm Investors L.P.
Files at TGAN (Transphorm, Inc.). First filing Jun 20, 2024, latest Jun 20, 2024.
In brief
KKR Phorm Investors L.P. files SEC Form 4 as 10% owner at TGAN (Transphorm, Inc.). Since Jun 20, 2024, KKR Phorm Investors L.P. has reported 0 open-market buys worth $0 and 1 open-market sell worth $125M, the latest filed on Jun 20, 2024.
A track record needs three past buys with six months of prices behind them; KKR Phorm Investors L.P. has 0, so none is measured yet.
The newest scored trade: sold $125M of TGAN on Jun 20, 2024, filed Jun 20, 2024, scored 57 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 57Moderate | TGANsell Transphorm, Inc. | $125M 24,411,968 shares | -100% | - |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | TGAN Transphorm, Inc. | SOpen-market sale Common Stockindirect: See footnotes | -24,411,968 | $5.10 | $125M | 0 | Jun 20, 2024 |
Questions about KKR Phorm Investors L.P.
Answered from the filings on this page, as of the latest one.
Is KKR Phorm Investors L.P. buying or selling?
Not in the last 12 months. KKR Phorm Investors L.P.'s latest open-market trade on SEC Form 4 was sold $125M of TGAN on Jun 20, 2024.
How did KKR Phorm Investors L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and KKR Phorm Investors L.P. has 0.
Where does KKR Phorm Investors L.P. file Form 4?
KKR Phorm Investors L.P. has filed Form 4 at TGAN (Transphorm, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.